Transplantation of human umbilical cord blood cells in the repair of CNS diseases

Bibliography

• BROXMEYER HE: Primitivehematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. Cancer Treat. Res. (1996) 84:139–148.
   PubMedGoogle Scholar
• MAYANI H, LANSDORP PM: Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells (1998) 16(3):153–165.
   PubMed Web of Science ®Google Scholar
• NATIONAL CENTER FOR FARMWORKERS: National Vital Statistics Reports. Centers for Disease Control and Prevention, USA (2002).
   Google Scholar
• HOWS JM, MARSH JC, BRADLEY BA et al.: Human cord blood: a source of transplantable stem cells? Bone Marrow Transplant. (1992) 9\(Suppl. 1):105–108.
   Google Scholar
• CARDOSO AA, LI ML, BATARD Pet al.: Release from quiescence of CD34+ CD38-human umbilical cord blood cells reveals their potentiality to engraft adults. Proc. Natl Acad. Sci. USA (1993) 90(18):8707–8711.
   Google Scholar
• METCALF D: Clonal Culture of Hemopoietic Cells: Techniques and Applications. Elsevier Science Publishers B.V., The Netherlands (1984).
   Google Scholar
• BROXMEYER HE, HANGOC G, COOPER S et al.: Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc. Nati Acad. Sci. USA (1992) 89(9):4109–4113.
   PubMed Web of Science ®Google Scholar
• MIRAGLIA S, GODFREY W, YIN AH et al.: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood(1997) 90(12):5013–5021.
   PubMed Web of Science ®Google Scholar
• YIN AH, MIRAGLIA S, ZANJANI ED et al.: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood(1997) 90(12):5002–5012.
   PubMed Web of Science ®Google Scholar
• POTGENS AJ, BOLTE M,HUPPERTZ B, KAUFMANN P,FRANK HG: Human trophoblast contains an intracellular protein reactive with an antibody against CD 133-a novel marker for trophoblast. Placenta (2001) 22(7):639–645.
   PubMed Web of Science ®Google Scholar
• UCHIDA N, BUCK DW, HE D et al: Direct isolation of human central nervoussystem stem cells. Proc. Natl. Acad. Sci. USA (2000) 97(26):14720–14725.
   PubMed Web of Science ®Google Scholar
• TAMAKI S, ECKERT K, HE D et al: Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. I Neurosci. Res. (2002) 69(6):976–986.
   PubMed Web of Science ®Google Scholar
• BROXMEYER HE, SROUR EF, HANGOC G, COOPERS,ANDERSON SA, BODINE DM: High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc. Natl. Acad. Sci. USA (2003) 100(2):645–650.
   PubMed Web of Science ®Google Scholar
• BROXMEYER HA: Cellular Characteristics of Cord Blood and Cord Blood Transplantation. Broxmeyer HA (Ed.), AABB Press, Bethesda, MA, USA (1998).
   Google Scholar
• ORLIC D, GIRARD LJ, JORDAN CT, ANDERSON SM, CLINE AP,BODINE DM: The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. USA (1996) 93(20):11097–11102.
   PubMed Web of Science ®Google Scholar
• ORLIC D, GIRARD LJ, ANDERSON SM et al.: Transduction efficiency of cell lines and hematopoietic stem cells correlates with retrovirus receptor mRNA levels. Stem Cells (1997) 15\(Suppl. 1):23–28;discussion 28–29.
   Google Scholar
• GLUCKMAN E, ROCHA V,BOYER-CHAMMARD A et al.: Outcome of cord-blood transplantation from related and unrelated donors. EurocordTransplant Group and the European Blood and Marrow Transplantation Group. N Engl.Med. (1997) 337(6):373–381.
   Google Scholar
• WAGNER JE, BROXMEYER HE, BYRD RL et al.: Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood (1992) 79(7):1874–1881.
   PubMed Web of Science ®Google Scholar
• WAGNER JE, KERNAN NA, STEINBUCH M, BROXMEYER HE, GLUCKMAN E: Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet (1995) 346(8969):214–219.
   PubMed Web of Science ®Google Scholar
• VAZIRI H, DRAGOWSKA W,ALLSOPP RC, THOMAS TE,HARLEY CB, LANSDORP PM: Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.Proc. Natl. Acad. ScL USA (1994) 91(21):9857–9860.
   Google Scholar
• MIYAWAKI T, MORIYA N,NAGAOKI T, TANIGUCHI N: Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood. Immunol Rev (1981) 57:61–87.
   PubMed Web of Science ®Google Scholar
• NAGAOKI T, MIYAWAKI T,CIORBARU R et al.: Maturation of B cell differentiation ability and T cell regulatory function during child growth assessed in a Nocardia water soluble mitogen-driven system. J. linnaunol. (1981) 126(5):2015–2019.
   Google Scholar
• UENO Y, MIYAWAKI T, SEKI H et al.: Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.Immunol (1985) 135(1):180–184.
   Web of Science ®Google Scholar
• WILSON CB, WESTALL J, JOHNSTON L, LEWIS DB,DOWER SK, ALPERT AR: Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. Clin. Invest. (1986) 77(3)860–867.
   Google Scholar
• COHEN RI, MCKAY R, ALMAZAN G: Cyclic AMP regulates PDGF-stimulated signal transduction and differentiation of an immortalized optic-nerve-derived cell line.Exp. Biol. (1999) 202\(Pt 4):461–473.
   Google Scholar
• LU L, SHEN RN, BROXMEYER HE: Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Grit. Rev Oncol Hematol (1996) 22(2):61–78.
   PubMed Web of Science ®Google Scholar
• GLUCKMAN E, BROXMEYER HA, AUERBACH AD et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl.Med. (1989) 321(17):1174–1178.
   PubMed Web of Science ®Google Scholar
• BROXMEYER HE, GLUCKMAN E, AUERBACH A et al.: Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/ progenitor cells. hat. j. Cell Cloning (1990) 8\(Suppl. 1):76–89; discussion 89–91.
   Google Scholar
• LAUGHLIN MJ, BARKER J, BAMBACH B et al.: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl. I Med. (2001) 344(24):1815–1822.
   PubMed Web of Science ®Google Scholar
• BROXMEYER HE: Growth factors and cord blood stem and progenitor cells. Immunol Invest. (1995) 24(1-2):391–402.
   PubMed Web of Science ®Google Scholar
• CARDOSO AA, LI ML, BATARD P et al: Human umbilical cord blood CD34+ cell purification with high yield of early progenitors. J. Hematother: (1993) 2(2):275–279.
   PubMedGoogle Scholar
• LU L, XIAO M, SHEN RN, GRIGSBY S, BROXMEYER HE: Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replicating potential. Blood (1993) 81(1):41–48.
   PubMed Web of Science ®Google Scholar
• RAPPOLD I, ZIEGLER BL, KOHLER I et al.: Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood (1997) 90(1):111–125.
   PubMed Web of Science ®Google Scholar
• TRAYCOFF CM, ABBOUD MR, LAVER J et al: Evaluation of the M vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp. Hematol (1994) 22(2):215–222.
   PubMed Web of Science ®Google Scholar
• MUJTABA T, PIPER DR, KALYANI A, GROVES AK, LUCERO MT, RAO MS: Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev. Biol. (1999) 214(1):113–127.
   PubMed Web of Science ®Google Scholar
• CARPENTER MK, INOKUMA MS, DENHAM J, MUJTABA T, CHIU CP, RAO MS: Enrichment of neurons and neural precursors from human embryonic stem cells. Exp. Neurol (2001) 172(2):383–397.
   PubMed Web of Science ®Google Scholar
• DIETRICH J, NOBLE M,MAYER-PROSCHEL M: Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Clio (2002) 40(1):65–77.
   Google Scholar
• LENDAHL U, ZIMMERMAN LB, MCKAY RD: CNS stem cells express a new class of intermediate filament protein. Cell (1990) 60(4):585–595.
   PubMed Web of Science ®Google Scholar
• REYNOLDS BA, WEISS S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (1992) 255(5052):1707–1710.
   PubMed Web of Science ®Google Scholar
• PALMER TD, MARKAKIS EA, WILLHOITE AR, SAFAR F, GAGE FH: Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cellsfrom diverse regions of the adult CNS. Neurosci. (1999) 19(19):8487–8497.
   PubMed Web of Science ®Google Scholar
• JOHANSSON CB, SVENSSON M, WALLSTEDT L, JANSON AM, FRISEN J: Neural stem cells in the adult human brain. Exp. Cell Res. (1999) 253(2):733–736.
   PubMed Web of Science ®Google Scholar
• SHIH CC, WENG Y, MAMELAK A, LEBON T, HU MC, FORMAN SJ: Identification of a candidate human neurohematopoietic stem-cell population. Blood(2001) 98(8):2412–2422.
   PubMed Web of Science ®Google Scholar
• POLTAVTSEVA RA, MAREY MV, ALEKSANDROVA MA,REVISHCHIN AV, KOROCHKIN LI, SUKHIKH GT: Evaluation of progenitor cell cultures from human embryos for neurotransplantation. Brain Res. Dev. Brain Res. (2002) 134(1-2):149–154.
   PubMedGoogle Scholar
• KUKEKOV VG, LAYWELL ED, SUSLOV 0 et al.: Multipotent stem/ progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol (1999) 156(2):333–344.
   Google Scholar
• SANCHEZ-RAMOS JR, SONGS, KAMATH SG et al.: Expression of neural markers in human umbilical cord blood. Exp. Neurol (2001) 171(1):109–115.
   PubMed Web of Science ®Google Scholar
• HAY, CHOI JU, YOON DH et al.: Neural phenotype expression of cultured human cord blood cells M vitro. Neuroreport (2001) 12(16):3523–3527.
   PubMed Web of Science ®Google Scholar
• BICKNESE AR, GOODWIN HS, QUINN CO, VERNEAKE CD: Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant. (2002) 11(3):261–264.
   PubMed Web of Science ®Google Scholar
• •This is a key paper demonstrating evidence that umbilical cord blood-derived stem cells have the capacity to differentiate into neural cells.
   Google Scholar
• BUZANSKA L, MACHAJ EK, ZABLOCKA B, POJDA Z, DOMANSKA-JANIK K: Human cord blood-derived cells attain neuronal and glial features M vitro. J. Cell Sci. (2002) 115(Pt 10):2131–2138.
   PubMed Web of Science ®Google Scholar
• ZIGOVA T, SONGS, WILLING AE et al:Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant. (2002) 11(3):265–274.
   PubMed Web of Science ®Google Scholar
• •This paper describes the differentiating properties of HUCB cells in a neonatal animal model.
   Google Scholar
• CHEN J, SANBERG PR, LI Y et al.: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke (2001) 32(11):2682–2688.
   PubMed Web of Science ®Google Scholar
• ••This paper shows that intravenousinjections of HUCB migrate to the site of injury and improve functional recovery in stroke.
   Google Scholar
• WILLING AE, LIXIAN J, MILLIKEN M et al.: Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. (2003) 73(3):296–307.
   PubMed Web of Science ®Google Scholar
• ••This is a key paper comparing HUCBroutes of administration for stroke in an animal model, which also demonstrates the therapeutic potential of cord blood stem cells for stroke.
   Google Scholar
• BORLONGAN CV, HADMAN M, YU G, LIND JG, DAVIS CD, SANBERG PR: Upregulation of CNS trophic factors by human umbilical cord transplants is essential for neuroprotection against acute stroke. Soc. Neurosci. Abstract (2003) 789.17:
   Google Scholar
• BORLONGAN CV, EMERICH DF: Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport. Brain Res. Bull. (2003) 60(3):297–306.
   PubMed Web of Science ®Google Scholar
• LU D, SANBERG PR, MAHMOOD A et al.: Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. (2002) 11(3):275–281.
   PubMed Web of Science ®Google Scholar
• SAPORTA S, KIM JJ, WILLING AE, FU ES, DAVIS CD, SANBERG PR: Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. Hematother. Stem Cell Res. (2003) 12(3):271–278.
   PubMedGoogle Scholar
• •This paper describes an excellent potential of umbilical cord blood for treatment of spinal cord injury.
   Google Scholar
• GARBUZOVA-DAVIS S, WILLING AE, ZIGOVA T et al.: Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.Hematother. Stem Cell Res. (2003) 12(3):255–270.
   Google Scholar
• •This paper demonstrates that systemic administration of HUCB cells into presymptomatic ALS mice delayed diseaseprogression, increased lifespan, andexpressed neural markers in the brain, spinal cord, and parenchyma.
   Google Scholar
• WATSON DJ, LONGHI L, LEE EB et al:Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury. I Neuropathol Exp. Neurol (2003) 62(4):368–380.
   PubMed Web of Science ®Google Scholar
• MITTA B, RIMANN M,EHRENGRUBER MU et al.: Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction. Nucleic Acids Res. (2002) 30(21):e113.
   Google Scholar
• FALK A, HOLMSTROM N, CARLEN M, CASSIDY R, LUNDBERG C, FRISEN J: Gene delivery to adult neural stem cells. Exp. Cell Res. (2002) 279(1):34–39.
   PubMed Web of Science ®Google Scholar
• ROSENQVIST N,HARD AF SEGERSTAD C, SAMUELSSON C, JOHANSEN J, LUNDBERG C: Activation of silenced transgene expression in neural precursor cell lines by inhibitors of histone deacetylation.Gene Med. (2002) 4(3):248–257.
   Google Scholar
• BUCHET D, SERGUERA C,ZENNOU V, CHARNEAU P, MALLET J: Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. MM. Cell. Neurosci. (2002) 19(3):389–401.
   PubMed Web of Science ®Google Scholar
• HUGHES SM, MOUSSAVI-HARAMI F, SAUTER SL, DAVIDSON BL: Viral-mediated gene transfer to mouse primary neural progenitor cells. MM. Ther: (2002) 5(1):16–24.
   PubMed Web of Science ®Google Scholar
• WOODS NB, MUESSIG A,SCHMIDT M et al.: Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood (2003) 101(4):1284–1289.
   Google Scholar
• WOODS NB, MIKKOLA H,NILSSON E, OLSSON K, TRONO D, KARLSSON S: Lentiviral-mediated gene transfer into haematopoietic stem cells. J. Intern. Med. (2001) 249(4):339–343.
   PubMed Web of Science ®Google Scholar
• LUTHER-WYRSCH A, COSTELLO E, THALI M et al.: Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum. Gene Ther. (2001) 12(4):377–389.
   PubMed Web of Science ®Google Scholar
• WEISS ML, MITCHELL KE, HIX JE et al.: Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp. Neural. (2003) 182(2):288–299.
   PubMed Web of Science ®Google Scholar
• ENDE N, WEINSTEIN F, CHEN R, ENDE M: Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. (2000) 67(1)53–59.
   Google Scholar
• ENDE N, CHEN R, ENDE-HAARRIS D: Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. J. Med. (2001) 32(3-4):241–247.
   PubMedGoogle Scholar
• ENDE N, CHEN R: Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice. J. Med. (2001) 32(3-4):231–240.
   PubMedGoogle Scholar
• ENDE N, CHEN R, MACK R: NOD/LtJ type I diabetes in mice and the effect of stemn cells (Berashis) derived from human umbilical cord blood. J. Med. (2002) 33:(1-4):181–187.
   PubMedGoogle Scholar
• ENDE N, CHEN R: Parkinson's disease mice and human umbilical cord blood. J. Med. (2002) 33(1-4):173–180.
   PubMedGoogle Scholar